MGM Healthcare has launched Swayam, Chennai's first comprehensive multidisciplinary geriatric programme. This structured continuity-of-care model integrates outpatient, inpatient, and home-based services to restore and sustain quality of life...
Complex generics and biosimilars are reshaping global pharma. As patents expire and demand rises, 2026 marks a turning point for innovation, competition, and access.
Lupin Limited has ranked among the top 1% globally in the S&P Global Corporate Sustainability Assessment, scoring 91 out of 100 and emerging as the top pharmaceutical company worldwide.
LTM has entered a seven-year, $100 million partnership with a leading European MedTech company specializing in hearing solutions, focusing on product development, digital support, and compliance management for hearing devices.
Mahajan Imaging & Labs reports an 85% rise in Calcium Scoring CT and 36% growth in advanced cardiac scans, highlighting early heart risk among young Indians and the need for preventive cardiology.
Dr Reddy's Laboratories is preparing to launch its generic semaglutide injection in India by March following patent expiry, aiming to offer a significantly lower-cost option for diabetes and weight-loss patients.
Gilead Sciences is acquiring Arcellx in a deal valued at up to $7.8 billion, gaining full control of its CAR-T therapy candidate for multiple myeloma and strengthening its oncology pipeline.
Boehringer Ingelheim India has signed a landmark MoU with NIPER Raebareli to advance pharmaceutical innovation, strengthen research in novel drug delivery systems, and support academic collaboration in India’s evolving healthcare ecosystem.
BahiaFarma has joined hands with Biocon Biologics and Bionovis to develop and manufacture Pertuzumab for HER2-positive breast cancer, strengthening Brazil’s public healthcare supply and deepening India-Brazil pharma collaboration.
Merck and Mayo Clinic have joined forces in a major AI-driven research deal aimed at reshaping drug discovery. The collaboration blends advanced analytics, genomic data, and clinical expertise to speed up new therapy development.